Corbus Pharmaceuticals Holding (CRBP) Insider Trading
- $42,913,851.27
- $3,500,316.12
- Sept. 20, 2024
- Sean F Moran
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 20, 2024 | Major Shareholder | 350,000 | $20.01 | Buy | $7,003,500.00 | |
June 18, 2024 | CFO | 1,958 | $42.12 | Sell | $82,470.96 | |
June 17, 2024 | CEO | 11,103 | $46.02 | Sell | $510,960.06 | |
June 14, 2024 | CFO | 9,355 | $49.87 | Sell | $466,533.85 | |
June 14, 2024 | CEO | 29,317 | $50.17 | Sell | $1,470,833.89 | |
March 7, 2024 | Major Shareholder | 250,000 | $40.05 | Buy | $10,012,500.00 | |
Feb. 2, 2024 | Major Shareholder | 750,000 | $19.00 | Buy | $14,250,000.00 | |
Jan. 26, 2024 | Major Shareholder | 282,632 | $32.24 | Buy | $9,112,055.68 | |
Aug. 10, 2022 | CFO | 20,000 | $0.26 | Buy | $5,200.00 | |
Aug. 10, 2022 | COO | 5,000 | $0.25 | Buy | $1,250.00 | |
Aug. 10, 2022 | CEO | 3,800 | $0.26 | Buy | $988.00 | |
May 16, 2022 | CFO | 12,000 | $0.30 | Buy | $3,600.00 | |
May 16, 2022 | CEO | 10,500 | $0.25 | Buy | $2,625.00 | |
March 10, 2022 | CFO | 15,000 | $0.37 | Buy | $5,550.00 | |
March 10, 2022 | COO | 10,000 | $0.37 | Buy | $3,700.00 | |
March 9, 2022 | CEO | 8,600 | $0.37 | Buy | $3,182.00 | |
Dec. 21, 2020 | CFO | 87,500 | $1.75 | Sell | $153,125.00 | |
Dec. 18, 2020 | CFO | 53,610 | $1.40 | Sell | $75,054.00 | |
Dec. 16, 2020 | CFO | 36,923 | $1.32 | Sell | $48,738.36 | |
Nov. 11, 2020 | CEO | 4,240 | $1.21 | Buy | $5,130.40 | |
Nov. 11, 2020 | CEO | 4,240 | $1.21 | Buy | $5,130.40 | |
March 17, 2020 | Insider | 15,606 | $3.82 | Buy | $59,614.92 | |
March 17, 2020 | COO | 2,840 | $3.82 | Buy | $10,848.80 | |
Nov. 12, 2019 | CEO | 1,430 | $4.26 | Buy | $6,091.80 | |
Nov. 11, 2019 | COO | 2,500 | $4.62 | Buy | $11,550.00 | |
Nov. 11, 2019 | Insider | 1,000 | $4.38 | Buy | $4,380.00 | |
Aug. 15, 2019 | Insider | 1,500 | $5.48 | Buy | $8,220.00 | |
Aug. 12, 2019 | Insider | 1,500 | $6.00 | Buy | $9,000.00 | |
Aug. 12, 2019 | COO | 15,000 | $5.86 | Buy | $87,900.00 | |
Aug. 12, 2019 | CEO | 1,175 | $6.06 | Buy | $7,120.50 | |
May 17, 2019 | Insider | 1,389 | $7.20 | Buy | $10,000.80 | |
May 14, 2019 | CFO | 100 | $7.12 | Buy | $712.00 | |
May 14, 2019 | Insider | 1,000 | $7.23 | Buy | $7,230.00 | |
May 13, 2019 | CEO | 995 | $6.99 | Buy | $6,955.05 | |
March 15, 2019 | Director | 1,000 | $6.98 | Buy | $6,980.00 | |
March 14, 2019 | CFO | 1,500 | $6.67 | Buy | $10,005.00 | |
March 14, 2019 | CEO | 1,530 | $6.49 | Buy | $9,929.70 | |
March 14, 2019 | Insider | 4,638 | $6.47 | Buy | $30,007.86 | |
May 15, 2018 | CEO | 1,725 | $5.85 | Buy | $10,091.25 | |
May 15, 2018 | CFO | 4,000 | $5.77 | Buy | $23,080.00 | |
May 15, 2018 | Insider | 2,586 | $5.87 | Buy | $15,179.82 | |
May 14, 2018 | Director | 5,000 | $5.48 | Buy | $27,400.00 | |
March 14, 2018 | Director | 5,000 | $6.67 | Buy | $33,350.00 | |
March 14, 2018 | Insider | 2,885 | $6.89 | Buy | $19,877.65 | |
March 14, 2018 | CFO | 3,100 | $6.60 | Buy | $20,460.00 | |
March 14, 2018 | CEO | 1,160 | $6.89 | Buy | $7,992.40 | |
Nov. 15, 2017 | Director | 5,000 | $6.55 | Buy | $32,750.00 | |
Nov. 13, 2017 | Director | 5,000 | $6.90 | Buy | $34,500.00 | |
Nov. 10, 2017 | Insider | 2,836 | $7.00 | Buy | $19,852.00 | |
Nov. 10, 2017 | CEO | 1,000 | $7.17 | Buy | $7,170.00 |
Insiders are both buying and selling Corbus Pharmaceuticals Holding stock.
The insider traders at Corbus Pharmaceuticals Holding are: Sean F Moran, Barbara White, Yuval Cohen, David P Hochman, Craig Stuart Millian, Cormorant Asset Management, Lp, Robert Paul Discordia, Avery W Catlin, Sumner Burstein, John Kenneth Jenkins, Alan F Holmer, Mark Tepper, and Renu Gupta
The most active insider trader at Corbus Pharmaceuticals Holding is Sean F Moran with 49 trades.
Yuval Cohen has sold the most Corbus Pharmaceuticals Holding stock with a total value of $2,492,754.01.
Cormorant Asset Management, Lp has bought the most Corbus Pharmaceuticals Holding stock with a total value of $47,381,555.68.
The most recent insider trade for Corbus Pharmaceuticals Holding was on Sept. 20, 2024.
The single biggest insider buy for Corbus Pharmaceuticals Holding was from Cormorant Asset Management, Lp with a total value of $14,250,000.00 on Feb. 2, 2024.
The single biggest insider sell for Corbus Pharmaceuticals Holding was from Yuval Cohen with a total value of $1,470,833.89 on June 14, 2024.